Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV

被引:7
|
作者
Kay, Alexander W. [1 ,2 ,3 ]
Thivalapill, Neil [3 ,4 ]
Skinner, Donald [5 ]
Dube, Gloria Sisi [6 ]
Dlamini, Nomathemba [3 ]
Mzileni, Bulisile [3 ]
Fuentes, Patricia [1 ,2 ,3 ]
Ustero, Pilar [1 ,2 ,3 ]
Adams, Lisa V. [7 ]
Mandalakas, Anna M. [1 ,2 ,3 ]
机构
[1] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Global TB Program, Sect Global & Immigrant Hlth, Houston, TX 77030 USA
[3] Baylor Coll Med Childrens Fdn, Mbabane, South Africa
[4] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
[5] Human Sci Res Council, HIV AIDS STDs & TB, Cape Town, South Africa
[6] Minist Hlth, Natl TB Control Program, Mbabane, South Africa
[7] Dartmouth Coll, Geisel Sch Med, Sect Infect Dis & Int Hlth, Hanover, NH 03755 USA
来源
PLOS ONE | 2020年 / 15卷 / 12期
基金
美国国家卫生研究院;
关键词
D O I
10.1371/journal.pone.0243713
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study identified factors associated with adherence to a 6-month isoniazid preventive therapy (IPT) course among adolescents and children living with HIV. Forty adolescents living with HIV and 48 primary caregivers of children living with HIV completed a Likert-based survey to measure respondent opinions regarding access to care, quality of care, preferred regimens, perceived stigma, and confidence in self-efficacy. Sociodemographic data were collected and adherence measured as the average of pill counts obtained while on IPT. The rates of suboptimal adherence (< 95% adherent) were 22.5% among adolescents and 37.5% among the children of primary caregivers. Univariate logistic regression was used to model the change in the odds of suboptimal adherence. Independent factors associated with suboptimal adherence among adolescents included age, education level, the cost of coming to clinic, stigma from community members, and two variables relating to self-efficacy. Among primary caregivers, child age, concerns about stigma, and location preference for meeting a community-health worker were associated with suboptimal adherence. To determine whether these combined factors contributed different information to the prediction of suboptimal adherence, a risk score containing these predictors was constructed for each group. The risk score had an AUC of 0.87 (95% CI: 0.76, 0.99) among adolescents and an AUC of 0.76 (95% CI: 0.62, 0.90), among primary caregivers suggesting that these variables may have complementary predictive utility. The heterogeneous scope and associations of these variables in different populations suggests that interventions aiming to increase optimal adherence will need to be tailored to specific populations and multifaceted in nature. Ideally interventions should address both long-established barriers to adherence such as cost of transportation to attend clinic and more nuanced psychosocial barriers such as perceived community stigma and confidence in self-efficacy.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] HIV, Pregnancy, and Isoniazid Preventive Therapy
    Tiendrebeogo, Thierry
    Anglaret, Xavier
    Becquet, Renaud
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (12): : 1184 - 1184
  • [32] Isoniazid preventive therapy in HIV infection
    Dodd, Lori Elizabeth
    Wilkinson, Robert John
    [J]. LANCET, 2011, 377 (9777): : 1548 - 1550
  • [33] Equity in adherence to antiretroviral therapy among economically vulnerable adolescents living with HIV in Uganda
    Bermudez, Laura Gauer
    Jennings, Larissa
    Ssewamala, Fred M.
    Nabunya, Proscovia
    Mellins, Claude
    McKay, Mary
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2016, 28 : 83 - 91
  • [34] Implementation of isoniazid preventive therapy in people living with HIV in Zambia: challenges and lessons
    Kagujje, Mary
    Mubiana, Muhau L.
    Mwamba, Eugenia
    Muyoyeta, Monde
    [J]. BMC PUBLIC HEALTH, 2019, 19 (01)
  • [35] Implementation of isoniazid preventive therapy in people living with HIV in Zambia: challenges and lessons
    Mary Kagujje
    Muhau L. Mubiana
    Eugenia Mwamba
    Monde Muyoyeta
    [J]. BMC Public Health, 19
  • [36] Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions
    Getahun, Haileyesus
    Granich, Reuben
    Sculier, Delphine
    Gunneberg, Christian
    Blanc, Leopold
    Nunn, Paul
    Raviglione, Mario
    [J]. AIDS, 2010, 24 : S57 - S65
  • [37] Efficacy, safety, and tolerability of isoniazid preventive therapy for tuberculosis in people living with HIV
    Jagi, Jaya Laxmi
    Thomas, Christy
    Gudi, Sai Krishna
    Undela, Krishna
    [J]. AIDS, 2023, 37 (03) : 455 - 465
  • [38] Isoniazid preventive therapy for HIV infected children: Impact on incidence of tuberculosis?
    Mitchell, C. D.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 55 - 55
  • [39] Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts
    Assefa, Dawit Getachew
    Zeleke, Eden Dagnachew
    Bekele, Delayehu
    Ejigu, Dawit A.
    Molla, Wondwosen
    Woldesenbet, Tigist Tekle
    Aynalem, Amdehiwot
    Abebe, Mesfin
    Mebratu, Andualem
    Manyazewal, Tsegahun
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 (01)
  • [40] Implementation of Isoniazid Preventive Therapy among People Living with HIV in Northwestern Nigeria: Completion Rate and Predictive Factors
    Adepoju, Abiola Victor
    Ogbudebe, Chidubem L.
    Adejumo, Olusola Adedeji
    Okolie, Johnson
    Inegbeboh, Jude O.
    [J]. JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2020, 12 (02) : 105 - 111